chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Migraines triggered after both doses; her left arm was still hurting/ Left arm pain at injection site; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 34 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergies" (ongoing), notes: Seasonal allergies. Concomitant medication(s) included: ALLEGRA taken for hypersensitivity. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 29Apr2021, outcome "unknown", described as "her left arm was still hurting/ Left arm pain at injection site"; FATIGUE (non-serious) with onset 29Apr2021, outcome "unknown", described as "fatigue"; MIGRAINE (non-serious), outcome "unknown", described as "Migraines triggered after both doses". The patient underwent the following laboratory tests and procedures: cardiac stress test: normal; laboratory test: normal, notes: for UTI; magnetic resonance imaging: normal, notes: checked for neuropathy; ultrasound bladder: normal.  Additional Information: Initially, she had symptoms where she felt fatigued during 1st dose for 3 weeks and did not think she had any side effects outside of that. It started on the same date as first dose around 28May2021 or something like that. She later corrected to 28Apr2021 for her first dose. She also had Left arm pain at injection site that lasted until 3-4 weeks which was still painful when she got her 2nd injection. Other than allergies she never had any health issues.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a nurse referring to 2 unspecified patients of unknown gender and age. Information about concurrent condition, drug reactions/allergies and medical history was unknown. Concomitant therapies included sterile diluent (manufacturer unknown). On 10-AUG-2017, 3 different unspecified patients were vaccinated with improperly stored PROQUAD (Lot# N004631, expiration date 07-AUG-2018) (strength, dose, and route unknown) for prophylaxis, the diluent (unspecified lot #'s and expiration dates) used to reconstitute the vaccine above was properly stored. The vaccine was stored at 6 to 14 degrees Fahrenheit for 15 hours and 45 minutes. There had not been a previous temperature excursion and the phone call was a result of the data logger. No adverse effects were reported. This is one of the several reports from the same reporter. Sender's Comments: US-009507513-708USA007019: US-009507513-1709USA009153: US-009507513-1709USA009150: US-009507513-1709USA009151: US-009507513-1708USA008578: US-009507513-1709USA007605: US-009507513-1709USA007604: US-009507513-1709USA007603: US-009507513-1709USA007602: US-009507513-1709USA007601.
approx 2.5 hr post vax pt refused feeding, became limp & pale & hyporesponsive.Had some difficulty swallowing; was responsive to stimulation. Had temp of 100.8 degrees F (rectally) and then over 102 degrees. sx subsided approx 6 hr
Symmetric bilateral tingling in feet and low legs with more of a "pinging" sensation at random places and times over rest of her body and bilateral thigh soreness not resolved with rest; sxs worsening as time goes on.
Pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in the left arm) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain in the left arm). At the time of the report, VACCINATION SITE PAIN (Pain in the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not reported.
Tender, red, swollen, size of quarter 1st day, 2nd day size of a coffee cup, 3rd day less redness size increase of an inch but not as much as the 1st and 2nd day.
patient received fluad in pharmacy on 09/02/19 was feeling fine when she left the store. the next day she went to her cardiologist and told him she received her flu shot. the md then administered a pneumonia shot to her. patient developed tiredness and fever after the pneumonia shot the next day. a few days later patient called to say she had weakness and fell when she tried to get out of bed and hurt her ankle. she visited  md to examine her ankle.
Myalgia, Fever, NauseaVomiting, TENDER/SWOLLEN ARM, TIGHTNESS/PAIN IN CHEST
Patient received dose 1 of the Pfizer COVID vaccine (lot FF8839) at approximately 1215. At 1224, patient started fanning herself and reported feeling dizzy to her father. PHN approached to assess, patient reported feeling dizzy, hot, and sweaty. Skin pale. Patient transfered to zero-gravity chair unassisted and laid supine at 1226. At 1231, vital signs: blood pressure 96/62, pulse 88, O2 96%, respirations 18. Patient reported symptoms improved significantly after laying down, skin color pink. Patient reported a fear of needles and general anxiety but no history of syncope. Patient reported eating before arrival at vaccine site. No medical conditions, no medications, allergy to rabbits causing rash on contact. PHN advised patient to remain for 30min monitoring, to follow up with provider, and when to call emergency number. At 1236, patient reported all symptoms resolved. Vital signs: pulse 86, O2 96%, respirations 16, blood pressure 100/78. At 1238, patient stood up, continued to report no symptoms. At 1239, patient left against medical advice. Patient left walking with steady gait.
Lymph node on left side of neck swollen; Lymph node on left side of neck sore to touch; This is a spontaneous report received from a contactable consumer, the patient. An elderly no pregnant female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) unknown dose, via an unspecified route of administration in the left arm on 10Mar2021 (Lot/batch no: cW6206) expiration date not provided as a single dose for COVID-19 immunization. The patient's medical history included thyroid disorder, hypertension and high cholesterol. Concomitant medications were not reported. The patient did not have any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 08:00 am, the patient experienced lymph node on left side of neck swollen and sore to touch. No therapeutic measures were taken for the events. The clinical outcome of the events lymph node on left side of neck sore to touch and lymph node on left side of neck swollen were not recovered. No follow-up attempts are needed. No further information is expected.
Body aches , fatigue, nausea the day after. Felt better the next day then felt way worse Sunday and still feel fatigue.
vaccine was on 10/12/19  and patient per father started with symtoms on 10/19/2019   Patient started with  frequent urination during the day and night, and 2 weeks later   started with abdominal pain  ,  frequent drinking   , was seen at my office on 11/07/19 with polyuria , polyuria ,weight loss of 10 lbs and moderate to severe dehydration,  high blood pressure, and was diagnosed with new onset diabetes at the office +urine test and was sent to ER  where  diagnosed was confirm DM type I  and DKA, Patient was admitted to PICU.
persistent sore nodule @ inj site w/resultant local cellulitis rx Augmentin;
Different sensation on his left arm up to his neck; Facial numbness; First dose 10March2021 - Overdue second dose; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Different sensation on his left arm up to his neck), HYPOAESTHESIA (Facial numbness) and PRODUCT DOSE OMISSION ISSUE (First dose 10March2021 - Overdue second dose) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PARAESTHESIA (Different sensation on his left arm up to his neck), HYPOAESTHESIA (Facial numbness) and PRODUCT DOSE OMISSION ISSUE (First dose 10March2021 - Overdue second dose). At the time of the report, PARAESTHESIA (Different sensation on his left arm up to his neck) and HYPOAESTHESIA (Facial numbness) had not resolved and PRODUCT DOSE OMISSION ISSUE (First dose 10March2021 - Overdue second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not reported.
This is in follow-up to report(s) previously submitting on 5/15/2009. Information has been received from a pharmacist concerning a child (age unknown) who on an unspecified date was vaccinated with a dose of VARIVAX (Oka/Merck) (lot number not provided). The pharmacist reported that the mother may had developed varicella after her child received the vaccine. The reporter mentioned that the child was breast feeding at the time of transmission. The patient sought unspecified medical attention with a physician. The age of the child that received the VARIVAX (Oka/Merck) was unknown. At the time of the report, the pharmacist was uncertain if physician was interested in Polymerase Chain Reaction (PCR) analysis and he was not sure if positive transmission occurred. Additional information has been requested.
fevers, chills, myalgias, dizziness, diarrhea x 9 days
Pediatric dose was given to adults mistakenly; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly).    This case refers to patient 64 out 104.  Concomitant product use was not provided by the reporter.  It was reported the patient received the error dose with instruction to re-vaccinate 2 months from the initial error doses.  Treatment information was not provided.
This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN (read about an orthopedist who had "pain so bad" from the Moderna vaccine he can no longer practice anymore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (read about an orthopedist who had "pain so bad" from the Moderna vaccine he can no longer practice anymore). At the time of the report, PAIN (read about an orthopedist who had "pain so bad" from the Moderna vaccine he can no longer practice anymore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.No concomitant medication were provided.No treatment information were given.
April 13th i had the 1st Moderna shot and aside a sore arm I was perfectly fine. May 13 I had the 2nd shot and within 12h i got really sick, fever, cough, whole body shaking shivers. Lasted few days. Since then I have this cough that never left. It is not continuous, it is bouts of dry cough. Recently i started to spit watery transparent mucus. Note: we followed 100% covid restrictions since march 2020. Quarantine, social distancing, masks, etc. None of us ever got sick this whole time. My daughter is 13 and she had a cold in may but her school made us have her tested and she was covid negative.  Are there reports of people having  continuous cough bouts after the vaccine? My doctor says it shouldn't be related and my lungs sound fine I also have an oximeter and my 02/heart beats are perfect. No shortness of breath, no chest pain. Nothing. My husband had mild side effects from his vaccine but he healed after a few days. No one in the household has been sick recently.
I did not know I was pregnant at the time I received the first dose. They sent me directly to OB triage on 07/18/2021. I got something called HELLP syndrome and I had extremely high blood pressure, my platelets dropped very low, I had protein in my urine. I was in the hospital for a couple of days because my baby was born at 26 weeks. I had to be put on magnesium sulfate. I had to have an emergency c- section. My blood pressure remains elevated 7 weeks postpartum and I still have swelling in my legs. I still remain on blood pressure medications.  It is rare for symptoms to persist these long after delivery and I still have edema and high blood pressure.   Pregnancy history- first baby, I was considered  a high risk pregnancy, I had to go to the OB pretty often. I was supposed to be due at 35 weeks but my baby was born at 26. Otherwise it was pretty unremarkable, a lot of ultrasounds which were normal.  My baby's weight was 850 grams
Tenderness of injection site and armpit lymph nodes Muscle pain Joint pain Fever - 101 Chills
12 hours after vaccination, i experienced chills, fever, headache and very sore arm. My teeth were chattering and I was shivering. Symptoms last for next 72 hours but were on and off. This happened too when I got my 1st dose.
My entire body had hives; stomach as incredibly painful; manageable swelling (edema) and hives on my face, scalp, hands, arms, back, and feet.; manageable swelling (edema) and hives on my face, scalp, hands, arms, back, and feet.; manageable swelling (edema) and hives on my face, scalp, hands, arms, back, and feet.; experience some stomach discomfort; allergic to wheat or gluten intolerant; This is a spontaneous report from a contactable consumer (reported for himself). A 24-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EW0171), via an unspecified route of administration, administered in arm left on 03May2021 (age at vaccination was 24-year-old) as dose 2, single for covid-19 immunisation in school or student health clinic. The patient medical history and concomitant medications were not reported. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Previously, the patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: ER8729), via an unspecified route of administration, administered in arm left on 09Apr2021 (age at vaccination was 24-year-old) as single for COVID-19 immunisation. The patient was not diagnosed with COVID prior vaccination. Roughly two months (23Jul2021) after the second dose, the patient experienced random minor and manageable swelling (edema) and hives on my face, scalp, hands, arms, back, and feet and also experienced some stomach discomfort at times. This continued to occur for roughly two weeks, taking place hours after eating gluten/wheat without me realizing the connection because it was not severe enough for me to be worried. The patient had a severe outbreak in (23Jul2021) mid-July2021 hours after eating and drinking a large amount of gluten/wheat paired with many beers. Patient stated that "my entire body had hives, my face, hands, and feet were swollen, and my stomach as incredibly painful". Since this outbreak the patient had cut out gluten, wheat, and alcohol and had not experienced any symptoms since. On an unknown date 2021, the patient believes the vaccine made the patient allergic to wheat or gluten intolerant, as the patient was not previously allergic to these ingredients. As a result, the patient had to visit an urgent care site to receive a prednisone shot and antihistamine shot to subside the symptoms. Since the vaccination, the patient was not tested with COVID-19.  The outcome of the other events was resolved with sequel on an unknown date 2021. The outcome of the event allergic to wheat or gluten intolerant was unknown.  Follow-up attempts are completed. No further information is expected.
My daughter woke up in the morning complaining of leg pain. She was having difficulty walking as well. I contacted the pediatrician who sent her to see a neurosurgeon since symptoms were not improving. After several hours we arrived at hospital to only be seen by ER physician as symptoms were improving. This is the second year in a row that my daughter has had issues with her lower extremities following the nasal mist flu vaccine.
ANEMIC; IRON NOT AT A NORMAL LEVEL; VACCINE DID SOMETHING / UNSPECIFIED ADVERSE EVENT; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included iron level normal.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced anemic, iron not at a normal level, and vaccine did something / unspecified adverse event. Laboratory data (dates unspecified) included: Blood iron (NR: not provided) Abnormal. Treatment medications (dates unspecified) included: iron. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the anemic, vaccine did something / unspecified adverse event and iron not at a normal level was not reported. This report was non-serious.
This spontaneous report was received from a Register Nurse referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 23-DEC-2015 the patient was vaccinated with improperly stored dose of VARIVAX (Merck) lot # L029472, expiration date in: 06-AUG-2017 (dose and route were not provided). Concomitant therapies were not provided. The register nurse reported a temperature excursion with the following vaccine: VARIVAX (Merck), (Lot #: L029472 Expiration date on: 06-AUG-2017), Temperature: 7 degrees C, Time frame: 1 month, Outcome of excursion VARIVAX (Merck) must be used within 1 month. No adverse events were reported. No product quality complaint was involved. This is one of two cases from the same reporter (MARRS # 1601USA003459). Additional information has been requested.
A territory representative reported that a 6 month old male received his 1st dose of Prevnar, as well as, Tripedia and Act-Hib vaccines on 9/18/00. On 9/19/00, the infant developed rash described as looking "almost like prickly heat or roseola".
have an Easter egg sized red painful swelling; have an Easter egg sized red painful swelling; have an Easter egg sized red painful swelling; This is a spontaneous report from a contactable Physician (patient). A 51-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6198), via an unspecified route on 07Mar2021 (at the age of 51-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included known allergies to skin allergies to fragrances and certain cosmetics. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications in two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On unspecified date, the patient had an easter egg sized red painful swelling. It started within 12 hours. It was still there today 4 days later. Patient did not received treatment for events. The outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Itchy throat and swelling right eye. Hives on legs, Right deltoid mild erythema and ecchymosis. Was seen at ER on 4/16/2019 and prescribed Benadryl.
Patient came into pharmacy with hives all over body. Sent patient to local walk-in clinic where MD prescribed steroid and antihistamine for reaction.
temperature excursion on GARDASIL 9; No other adverse events - No signs or symptoms reported; Information has been received from a registered nurse reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication.  On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 mL for prophylaxis, lot# 1687293 and expiration date reported as 25-AUG-2022, but upon internal validation was established as 30-APR-2023 (route of administration not reported). No adverse events were reported.  On an unknown date, the vaccine underwent a temperature excursion of 47.1 Fahrenheit degree for 13 minutes. No previous temperature excursions were reported. The call was not placed because a digital data logger.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.  devicelotnumber: 1687293; expirationdate: 30-APR-2023; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2103USA005285: US-009507513-2104USA003211: US-009507513-2104USA003212: US-009507513-2104USA003213: US-009507513-2104USA003214: US-009507513-2104USA003215: US-009507513-2104USA003216: US-009507513-2104USA003217: US-009507513-2104USA003218: US-009507513-2104USA003219: US-009507513-2104USA003221: US-009507513-2104USA003222: US-009507513-2104USA003223: US-009507513-2104USA003224: US-009507513-2104USA003225: US-009507513-2104USA003196: US-009507513-2104USA003197: US-009507513-2104USA003198: US-009507513-2104USA003199: US-009507513-2104USA003200: US-009507513-2104USA003201: US-009507513-2104USA003202: US-009507513-2104USA003203: US-009507513-2104USA003204: US-009507513-2104USA003205: US-009507513-2104USA003206: US-009507513-2104USA003210: US-009507513-2104USA003207: US-009507513-2104USA003208: US-009507513-2104USA003209: